+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are evaluating how the study medicine CagriSema helps adults living with obesity, with or without type 2 diabetes, lose weight. This clinical trial compares two different doses of CagriSema with semaglutide, a medicine already prescribed for weight loss. The study aims to understand the safety and effectiveness of CagriSema in reducing body weight over time. Participants are randomly assigned to receive one of three treatments CagriSema at dose level 1, CagriSema at dose level 2, or semaglutide. Each treatment is given once weekly as a subcutaneous injection over a 72-week period. The study lasts about 83 weeks in total to include all treatment and follow-up time. During the study, participants will have regular visits for assessments including body weight, body mass index, waist circumference, cholesterol levels, and blood sugar control. Questionnaires on physical function and quality of life will also be completed. Researchers will track any side effects and serious adverse events throughout the study and after treatment ends, monitoring safety for up to 80 weeks.

Age: 18Years +All GendersPhase 3
303 locations
C

Actively Recruiting

Researchers are evaluating the best approach for managing asymptomatic kidney stones in children and adults. The study, called the Observational Approach versus Surgical Intervention for Asymptomatic Stone OASIS trial, aims to determine if observation or upfront surgery leads to less disruption in daily life due to kidney stones. It also seeks to identify which groups benefit most from each approach and understand patient preferences and values related to these treatment options. Participants will be randomly assigned to one of two groups observation or upfront surgery. Observation involves regular check-ups and imaging tests such as CT scans, ultrasounds, or x-rays to monitor the stones without immediate intervention. Upfront surgery includes planned procedures like ureteroscopy or shockwave lithotripsy to remove the stones. Additionally, up to 300 individuals who choose not to be randomized may join an observational cohort and be followed for two years. During the study, participants will be monitored every three months for up to two years. Assessments will include evaluating healthcare-related life disruptions, physical and emotional health aspects such as pain interference and anxiety, stone passage, and productivity impacts like missed school or work. The study collects data through clinic visits, imaging, and patient-reported questionnaires to understand the outcomes of each management strategy over time.

Age: 6Years +All GendersPhase Not Applicable
4 locations